Summary
Thermo Fisher Scientific Inc. (TMO) announced on November 24, 2014, the issuance of €640 million in aggregate principal amount of 2.000% Senior Notes due 2025. The notes were issued through a public offering and are intended to strengthen the company's balance sheet and fund its strategic objectives. The company plans to use the net proceeds of approximately €634.4 million to repay existing short-term and long-term indebtedness, specifically retiring commercial paper and reducing outstanding amounts under its term loan facility. This move suggests a focus on optimizing its debt structure and potentially lowering interest expenses.
Key Highlights
- 1Issuance of €640 million in 2.000% Senior Notes due 2025.
- 2Public offering of notes registered on Form S-3.
- 3Proceeds to be used for repaying existing short-term (commercial paper) and long-term (term loan) debt.
- 4Notes are general unsecured obligations, senior to subordinated debt but effectively subordinated to secured debt and structurally subordinated to subsidiary liabilities.
- 5Company has the option to redeem notes prior to maturity under specific conditions.
- 6A change of control coupled with a rating downgrade may trigger a mandatory repurchase offer from the company.
- 7Application made to list the Notes on the New York Stock Exchange (NYSE).
Frequently Asked Questions
The primary purpose is to refinance existing debt. Thermo Fisher Scientific plans to use the net proceeds to repay approximately €70.0 million of short-term indebtedness (commercial paper) and approximately €600.0 million of long-term indebtedness under its term loan facility. This indicates a strategy to optimize the company's debt maturity profile and potentially reduce borrowing costs.
The notes have a principal amount of €640 million, a coupon rate of 2.000% per annum, and mature on April 15, 2025. Interest is paid annually in arrears on April 15. The company has the option to redeem the notes, either in whole or in part, before maturity under specified conditions, and a mandatory repurchase offer may be triggered by a change of control event combined with a credit rating downgrade.
The notes are general unsecured obligations of Thermo Fisher Scientific. They rank equally in right of payment with other existing and future unsecured and unsubordinated indebtedness of the company. However, they are effectively subordinated to any secured indebtedness of the company to the extent of the assets securing such debt. They are also structurally subordinated to liabilities of the company's subsidiaries, meaning creditors of the subsidiaries would have a claim on subsidiary assets before any claims by Thermo Fisher Scientific on those assets.
By using the proceeds to repay existing debt, the company aims to manage its overall leverage. The refinancing of short-term commercial paper and a portion of its term loan with longer-term senior notes suggests a move towards a more stable and potentially lower-cost debt structure, which could positively impact its financial flexibility and debt servicing costs over the long term.